Dogwood Therapeutics, Inc. (DWTX) Discusses Halneuron and Pipeline Advances for Chemotherapy-Induced Neuropathic Pain Transcript
Follow Dogwood Therapeutics, Inc. (DWTX) Discusses Halneuron and Pipeline Advances for Chemotherapy-Induced Neuropathic Pain September 1, 2026 10:00 AM EDT Company Participants Greg Duncan – Chairman & CEOIain DukesR. Gendreau – Chief Medical Officer Conference Call Participants Mark JoyceJerry EvartsJason Mccarthy – Maxim Group LLC, Research DivisionXun Lee – H.C. Wainwright & Co, LLC, Research…